In February 2026, Jiuyuan Gene submitted a registration application for the weight-loss indication of semaglutide, challenging the status of being the first Chinese-produced weight-loss injection
GLP-1 Vision Loss GLP-1 Vision Loss Lawsuits Investigating Claims Involving Ozempic, Wegovy, and Sudden Vision Loss Grewal Law PLLC is investigating potential claims involving Ozempic, Wegovy, and other GLP-1 drugs after reports and litigation linked semaglutide to non-arteritic anterior ischemic optic neuropathy (NAION), a serious eye condition that can cause sudden and sometimes permanent vision loss
Contact your GP if you experience persistent palpitations, dizziness, chest pain, new shortness of breath, or a resting heart rate consistently above 100 beats per minute
I "promise" Novo Nordisk will "stay engaged" on helping to address these issues, he adds